Vienna, Austria and Bucharest, Romania on the 18th of June 2026
SOMAREALITY secures over €3 million in an oversubscribed Series A round led by Catalyst Romania to become the world’s first full cognitive insights solution based solely on eye tracking.
This marks the 13th investment for Catalyst Romania Fund II, with participation from SOMAREALITY’s existing investors MT-Lab, RDY Ventures, Moondust Ventures and Gateway Ventures.
SOMAREALITY is a deep tech startup from Vienna, Austria, that is on a mission to redefine what it means to understand cognitive processes, such as cognitive load, attention, perception, fatigue and overall performance based on a technology that is as non-invasive as it is real-time capable: eye tracking. With over €2 million revenue in B2B since the go-to-market with their first biomarker in 2024 and growing traction in high-risk industries such as aviation, healthcare, professional sports and in general research, SOMAREALITY has established a strong foothold in behavioural insights.
Purpose of the round
The fresh capital will go directly towards three strategic initiatives for 2026 and beyond: expansion of existing B2B segments, supporting freshly launched longitudinal studies for measuring and predicting cognitive health and human performance over time and, last but not least, powering a brand extension into B2C, reaching a whole new market to bring cognitive insights to anyone, anywhere.
Adrian Brodesser, co-founder of SOMAREALITY: “With our presence in B2B and the trust put in us by our clients and partners, we’ve proven that cognitive insights based on eye tracking is here to stay. Now, with persisting interest in personalized health as a whole and renewed interest in wearable eye tracking technology, we’re bringing our scientific underpinning to B2C and thereby to anyone who has always wanted to understand how their mind works but has never been able to outside of the lab.”
In 2025, SOMAREALITY has more than doubled their revenue compared to the previous year, driven by strategic partnerships with global leaders in eye tracking hardware solutions as well as software distributors across all continents. The company offers their solution both as local integration as well as web-based service. In addition, they are currently actualising on-chip deployment so that the technology can run seamlessly on any wearable glasses.
Alin Stanciu Partner at Catalyst Romania: “At Catalyst Romania, we aim to partner with companies that don’t just improve what already exists, but rethink entire industries – and SOMAREALITY is doing exactly that. By turning eye-tracking data into real-time insights about how people think, they are opening up a new way to better understand the human mind, with impact far beyond current use cases.
We believe this shift – from simply observing behavior to truly understanding how people think – has the potential to reshape sectors from healthcare to human performance and beyond. With this being our third investment in Central and Eastern Europe outside Romania, we’re excited to support the team as they build a global leader at the intersection of science and practical human insight. We have strong confidence in their ability to execute, their scientific expertise and their ambition to define this new space.”
About SOMAREALITY
SOMAREALITY is a software company that provides eye tracking algorithms to measure cognitive states in real-time. The solution is hardware agnostic and developed as a white-box approach, enabling accurate and personalised insights after only a few seconds of data. After launching their flagship product, Cognitive Load, which has quickly caught the interest of human behaviour-centric industries, the company has followed up with innovation in conscious perception, attention measurement, fatigue onset and soon overall cognitive performance and health.
www.somareality.com
About Catalyst Romania
Catalyst Romania is a pioneer in private equity and venture capital investments in Romania, having launched its first fund in 2012, financed through the JEREMIE initiative, and in late 2020 launched its second fund, Catalyst Romania Fund II. Catalyst Romania funds focus on providing early-stage and growth capital to young technology companies from Romania and Eastern Europe, which have the potential to become leaders in their sector in the region or achieve global success. Catalyst Romania Fund II is a VC fund managed by Catalyst II GP, both entities being established under Luxembourg law and acting as an alternative investment fund and, respectively, as an alternative investment fund manager.
www.catalystromania.com
About InnovFin Equity and JEREMIE Holding Fund Romania
Catalyst Romania Fund II is supported by (i) JEREMIE Holding Fund Romania, an investment program between EIF and the Government of Romania, under which EIF acts on behalf and for the ultimate benefit of the Government of Romania and invests the reflows generated by the operations implemented under the JEREMIE Holding Fund Romania during the eligibility period 2007-2013, and (ii) InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) established under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.
About EIF
The European Investment Fund is part of the European Investment Bank Group. Its central mission is to support Europe’s micro, small and medium-sized businesses by helping them to access finance. EIF designs and develops venture and growth capital, guarantees, and microfinance instruments which specifically target this market segment. In this role, EIF fosters EU objectives in support of innovation, research and development, entrepreneurship, growth, and employment.
www.eif.org
About MT-Lab
Medical Technology Lab (MT-Lab) is an operational holding company focused on supporting seed-stage and early-growth healthcare and life sciences companies in developing innovative products, technologies, and global businesses that advance human health. Leveraging deep expertise across research, development, clinical practice, operations, and finance, MT-Lab partners with visionary entrepreneurs to accelerate the translation of breakthrough scientific innovations into impactful healthcare solutions that benefit patients, healthcare professionals, and healthcare systems worldwide.
https://mt-lab.eu
About RDY Ventures
RDY Ventures is a Belgian early-stage venture capital fund, supporting tech entrepreneurs even before revenue is generated. Headquartered in Antwerp, Belgium, the firm writes EUR 100k within 3 weeks and provides up to EUR 1m in follow-on capital.
www.rdy.vc
About Moondust Ventures
Moondust Ventures is a venture capital firm focused on supporting exceptional early-stage startups in digital health, MedTech, biotech, and deep tech, with a strong emphasis on Central and Eastern Europe. The firm partners with ambitious founders developing breakthrough technologies that address critical healthcare and industrial challenges. Beyond capital, Moondust Ventures provides strategic guidance and hands-on support to help portfolio companies accelerate growth, navigate complex markets, and scale internationally. By backing innovative entrepreneurs at an early stage, Moondust Ventures contributes to the growth of the CEE innovation ecosystem and supports founders from the region to build world-class companies.
About Gateway Ventures
Gateway Ventures is a Vienna-based venture capital platform investing in ambitious early-stage technology companies across the DACH region and beyond. With more than 50 startups and 2 unicorns in its portfolio and around €30 million in assets under management, Gateway Ventures partners with founders building category-defining businesses, providing not only capital but also access to an extensive network of operators, industry experts and follow-on investors. Backing technically deep teams with global ambition, Gateway Ventures supports companies from their earliest stages through to scale, helping them turn breakthrough ideas into market-leading ventures.
https://gateway.ventures/en